Detection of antiischemic therapeutic effectiveness in patients with refractory angina pectoris and end-stage coronary artery disease - Long-term intermittent urokinase therapy;Antiischamischer wirkungsnachweis bei patienten mit therapierefraktarer angina pectoris im endstadium der koronaren herzkrankheit - Ergebnisse zur chronisch-intermittierenden urokinasetherapie

Zeitschrift fur Kardiologie

Volumn 87, Issue SUPPL. 2, 1998, Pages 188-192

  Schoebel, F C ^a   Peters, A J ^a   Schannwell, C M ^a   Holz, B ^a   Jax, T W ^a   Leschke, M ^a   Strauer, B E ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Angina pectoris; Coronary artery disease; Ischemic heart failure; Urokinase

Indexed keywords

UROKINASE;

ANGINA PECTORIS; CORONARY ARTERY DISEASE; DOPPLER ECHOCARDIOGRAPHY; DRUG INTERMITTENT THERAPY; ELECTROCARDIOGRAPHY; EXERCISE; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HEART SCINTISCANNING; HUMAN; LONG TERM CARE; RADIOISOTOPE VENTRICULOGRAPHY; REVIEW; DRUG ADMINISTRATION; DRUG EFFECT; FIBRINOLYTIC THERAPY; HEMODYNAMICS; TREATMENT OUTCOME;

ANGINA PECTORIS; CORONARY DISEASE; DRUG ADMINISTRATION SCHEDULE; HEMODYNAMIC PROCESSES; HUMANS; LONG-TERM CARE; THROMBOLYTIC THERAPY; TREATMENT OUTCOME; URINARY PLASMINOGEN ACTIVATOR;

EID: 0031725320     PISSN: 03005860     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003920050560     Document Type: Review

References (11)

1. Amsterdam EA, Hughes JL, DeMaria AN, Zelis R, Mason DT (1974) Indirect assessment of myocardial oxygen consumption in the evaluation of mechanisms and therapy of angina pectoris. Am J Cardiol 33: 737-743.
2. Hör G, Zöller A, Klepzig H, Hartmann A, Maul FD, Härtel A, Gürtner C, Kranert T, Baum RP (1994) Klinische Relevanz der Äquilibrium-Radionuklidventrikulographie.Med Klin 89: 442-452
3. Kelly DT (1997) Our future society - A global challenge. Circulation 95: 2459-2464
4. Leschke M, Schoebel FC, Mecklenbeck W, Stein D, Jax TW, Müller-Gärtner HW, Strauer BE (1996) Long-term intermittent urokinase therapy in patients with end-stage coronary artery disease and refractory angina pectoris: A randomized dose-response trial. J Am Coll Cardiol 27: 575-584.
5. Maisch B, Funck R, Schönian U, Moosdorf R (1996) Indikationen zur transmyokardialen Lasertherapie. Z Kardiol (Suppl. 6): 269-279
6. Nesto RW, Kowalchuk GJ (1987) The ischemic cascade: Temporal sequence of hemodynamic, electrocardiographic and symptomatic expressions of ischemia. Am J Cardiol 57: 23C-30C
7. Peters AJ, Schoebel FC, Neubaur TER, Strauer BE, Leschke M (1998) Long-term intermittent urokinase therapy and isovolumic hemodilution: a clinical and hemodynamic comparsion in patients with refractory angina pectoris. Angiology (in press)
8. Schoebel FC, Frazier OH, Jessurun GAJ, De Jongste MJL, Kadipasaoglu KA, Jax TW, Heintzen MP, Cooley DA, Strauer BE, Leschke M (1997) Refractory angina pectoris in end-stage coronary artery disease - Evolving therpeutic concepts. Am Heart J 134: 587-602
9. Schoebel FC, Leschke M, Jax TW, Stein D, Strauer BE (1996) Chronic-intermittent urokinase therapy in patients with end-stage coronary artery disease and refractory angina pectoris: A pilot study. Clin Cardiol 19: 115-120
10. Sheiban I, Tonni S, Marini A, Trevi G (1995) Clinical and therapeutic implications of chronic left ventricular dysfunction in coronary artery disease. Am J Cardiol 75: 23E-30E
11. 201Tl with SPECT. Nuc Med Comm 9: 15-23